Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 27 - Drugs for disorders of the senses
Patents for A61P 27 - Drugs for disorders of the senses (53,017)
06/2012
06/20/2012EP2364731A9 Methods of administering anti-TNFalpha antibodies
06/20/2012EP2359855A9 Methods of administering anti-TNFalpha antibodies
06/20/2012CN102510865A Nitrogen-containing spiro-ring compound and medicinal use of same
06/20/2012CN102505006A Modulation of stem and progenitor cell differentiation, assays, and uses thereof
06/20/2012CN102503959A Tricyclic compounds and preparation method thereof, and medicinal composition containing compounds and application thereof
06/20/2012CN102499987A Application of miR-1 in production of preparation for treating primary glaucoma
06/20/2012CN102499928A Pharmaceutical formulation comprising an antibiotic, a triazole and a corticosteroid
06/20/2012CN101912547B Medicament for treating dizziness and preparation method thereof
06/20/2012CN101870734B Fusogenic polypeptide for inhibiting neovascularization and coding gene and application thereof
06/19/2012US8202860 Methods and compositions for treating primary and secondary tumors of the central nervous system (CNS)
06/19/2012US8202855 Substituted beta-lactams
06/19/2012US8202845 Means and methods for the specific modulation of target genes in the CNS and the eye and methods for their identification
06/19/2012US8202840 Enhanced ocular neuroprotection and neurostimulation
06/19/2012US8202517 Soluble hyaluronidase glycoprotein (sHASEGP), process for preparing the same, uses and pharmaceutical compositions comprising thereof
06/19/2012CA2505138C Wipes
06/14/2012WO2012078647A2 Chemical composition to detect and treat amyloid in a patient's brain and retina
06/14/2012WO2012078525A2 Compositions and methods for treating ophthalmic conditions
06/14/2012WO2012078135A1 Oral care compositions comprising a quinone and a further antimicrobial agent
06/14/2012WO2012076877A1 Hydantoin derivatives useful as kv3 inhibitors
06/14/2012WO2012076831A1 [((1r,2s,5r)-2-isopropyl-5-methyl-cyclohexanecarbonyl)-amino]-acetic acid isopropyl ester and related compounds and their use in therapy
06/14/2012WO2012076685A1 Arylsulfonamide derivatives for the prevention or treatment of specific ophthalmologic disorders
06/14/2012WO2012076684A1 Dosages of arylsulfonamide derivatives
06/14/2012WO2012076323A1 Oligosaccharide composition for treating acute respiratory tract infections
06/14/2012WO2012075911A1 Use of recombinant human prx-6 protein in treatment of burn and scald and/or corneal injury
06/14/2012WO2012047706A9 Methods for promotiing reinnervation of auditory hair cells
06/14/2012WO2012031123A3 Method of treating ear infections
06/14/2012US20120149758 Pharmaceutical composition for preventing, stabilising and/or inhibiting blood and lymph vascularization
06/14/2012US20120149747 Pharmaceutical compositions comprising (3-(1-(1h-imidazol-4-yl)ethyl)-2-methylphenyl)methanol
06/14/2012US20120149746 Ester pro-drugs of [3-(1-(1h-imidazol-4-yl)ethyl)-2-methylphenyl] methanol for treating retinal diseases
06/14/2012US20120149730 Methods and compositions using racemic, (r)-, and (s)-fexofenadine in combination with leukotriene inhibitors
06/14/2012US20120149729 Metalloenzyme inhibitor compounds
06/14/2012US20120149707 Alpha-arylmethoxyacrylate derivative, preparation method thereof, and pharmaceutical composition containing same
06/14/2012US20120149696 Ethylene diamine modulators of fatty acid hydrolase
06/14/2012US20120149690 Compositions Comprising Azelastine and Methods of Use Thereof
06/14/2012US20120149673 Inhibitors of store operated calcium release
06/14/2012US20120148683 Immune stimulating composition comprising an extract of aronia sp. in combination with selenium and/or zinc
06/14/2012US20120148572 Novel antibodies
06/14/2012US20120148566 Product and method for treatment of conditions associated with receptor-desensitization
06/14/2012US20120148555 Soluble hyaluronidase glycoprotein (sHASEGP), process for preparing the same, uses and pharmaceutical compositions comprising thereof
06/14/2012US20120148543 Synthetic graft
06/14/2012US20120148540 Proliferated cell lines and uses thereof
06/14/2012US20120148536 Methods and storage and retrieval of functional mature retinal cells
06/14/2012US20120148509 Composition for alleviating ultraviolet irradiation-induced damage
06/14/2012US20120148495 Methods for treating nicotinic acetylcholine receptor associated diseases
06/14/2012CA2820124A1 Arylsulfonamide derivatives for the prevention or treatment of specific ophthalmologic disorders
06/14/2012CA2819951A1 Dosages of arylsulfonamide derivatives
06/14/2012CA2819466A1 [((1r,2s,5r)-2-isopropyl-5-methyl-cyclohexanecarbonyl)-amino]-acetic acid isopropyl ester and related compounds and their use in therapy
06/14/2012CA2818251A1 Oral care compositions comprising a quinone and a further antimicrobial agent
06/14/2012CA2818012A1 Oligosaccharide composition for treating acute respiratory tract infections
06/14/2012CA2817205A1 Hydantoin derivatives useful as kv3 inhibitors
06/13/2012EP2461809A2 Ophthalmic pharmaceutical compositions of dp2 receptor antagonists
06/13/2012EP1495053B1 Angiopoietin-2 and angiopoietin-1 specific binding agents
06/13/2012EP1414471B1 Therapeutic agents comprising pro-apoptotic proteins
06/13/2012EP1357912B9 Photodynamic therapy of occult choroidal neovascularization linked to age-related macular degeneration
06/13/2012EP1296705B1 Amyloid Beta oligomers for use in treatment, alleviation or prevention of Alzheimer's Disease
06/13/2012EP1235594B1 Inhibition of secretion from non-neuronal cells
06/13/2012CN102498105A Bicyclic compound and use thereof for medical purposes
06/13/2012CN102498091A Glycine compound
06/13/2012CN102497873A Compositions and methods for increasing lifespan and health span
06/13/2012CN102497872A Inhibitor of inflammatory conditions
06/13/2012CN102497865A Intraocular sustained release drug delivery systems and methods for treating ocular conditions
06/13/2012CN102492654A Kit for separating human umbilical cord blood stem cells and its using method
06/13/2012CN102488859A Traditional Chinese medicine composition for treating pinkeye
06/13/2012CN102488820A Traditional Chinese medicine composition for treating epicophosis
06/13/2012CN102488803A Preparation method for superfine bupleurum powder under normal temperature and special bidirectional airflow sieving machine
06/13/2012CN102488796A Multifunctional essential oil for ear, nose and eye and preparation method thereof
06/13/2012CN102488756A Medicament for treating dry eye syndrome
06/13/2012CN102488750A Xiasangju capsule and its preparation method
06/13/2012CN102488688A Ophthalmic preparation by taking fibrauretinumrecisapierre as main drug
06/13/2012CN102488674A Isoliquiritigenin eye drops and a preparation method thereof
06/13/2012CN102188596B Method for preparing Chinese medicine for treating toxic heat tympanitis
06/13/2012CN102000315B Traditional Chinese medicinal composition for treating dizziness and preparation method thereof
06/13/2012CN101869546B Supermolecular gel used for protecting photostability of vitamin A derivatives and its preparation method
06/13/2012CN101721363B Cefixime oral administration mixed suspension and preparation method thereof
06/13/2012CN101389221B Silver/water, silver gels and silver-based compositions, method for fabricating and using the same
06/12/2012US8198286 Sodium channel blockers
06/12/2012US8197814 Method for treating the Th2-mediated disease
06/12/2012US8197813 Human antibodies that bind human TNFα
06/07/2012WO2012075184A2 Cell lines that secrete anti-angiogenic antibody-scaffolds and soluble receptors and uses thereof
06/07/2012WO2012074926A1 Novel azetidine derivatives as sphingosine 1-phosphate (s1p) receptor modulators
06/07/2012WO2012074921A1 Alkyne and alkene derivatives as sphingosine 1-phosphate-1 receptor modulators
06/07/2012WO2012074788A1 Methods for treating diseases of the retina
06/07/2012WO2012074785A1 Pharmaceutical compositions comprising 3,4- dihydroisoquinolin-2(1 h)-yl-3-phenylurea derivatives having formyl peptide receptor like-1 (fprl-1) agonist or antagonist activity
06/07/2012WO2012074237A2 Liquid medicine composition including dorzolamide and brimonidine for ophthalmology
06/07/2012WO2012073856A1 Oil-in-water emulsion composition containing difluprednate and tobramycin
06/07/2012WO2012073237A1 Uridine di- or tri-phosphate derivatives and uses thereof
06/07/2012WO2012071772A1 :grape wine of nutritional enhancement
06/07/2012US20120142941 Composition for alleviating ultraviolet radiation-induced damage
06/07/2012US20120142783 Enhanced bimatoprost ophthalmic solution
06/07/2012US20120142782 Enhanced cimatoprost ophthalmic solution
06/07/2012US20120142766 Substituted 1,3-dioxanes and their uses
06/07/2012US20120142746 Ester pro-drugs of [3-(1-(1h-imidazol-4-yl)ethyl)-2-methylphenyl] methanol for lowering intraocular pressure
06/07/2012US20120142745 Novel phenyl oxadiazole derivatives as sphingosine 1-phosphate (s1p) receptor modulators
06/07/2012US20120142744 Novel complexes of fatty acid esters of polyhydroxyalkanes and pyridine carboxy derivatives
06/07/2012US20120142740 Novel alkene derivatives as sphingosine 1-phosphate (s1p) receptor modulators
06/07/2012US20120142739 Novel oxadiazole derivatives as sphingosine 1-phosphate (s1p) receptor modulators
06/07/2012US20120142736 Novel pyridine derivatives as sphingosine 1-phosphate (s1p) receptor modulators
06/07/2012US20120142735 Disubstituted [4-(5-aminomethyl-phenyl)-piperidin-1-yl]- 1h-indol-3-yl]-methanones
06/07/2012US20120142733 4-substituted-cyclohexylamino-4-piperidinyl-acetamide antagonists of ccr2
06/07/2012US20120142729 KAT ll INHIBITORS
1 ... 53 54 55 56 57 58 59 60 61 62 63 64 65 66 67 68 69 70 71 72 73 ... 531